Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sudeep Pharma has informed that the officials of the Company will be attending the Investor Conference on 28th September 2026 at 10:00 am onwards organised by Nuvama Emerging India CEO Forum 2026 in Mumbai. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.